Using Biperiden to Prevent Epilepsy After Brain Injury
Official title: Biperiden for Prevention of Epilepsy in Patients With Traumatic Brain Injury
Run by Hospital Sirio-Libanes · NCT04945213 · Data updated 2026-11-12
This study tests if the medication biperiden can help prevent seizures in adults who have had a serious brain injury.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 312 (estimated) |
| Sponsor | Hospital Sirio-Libanes Academic / other |
| Locations | 10 sites (Fortaleza, Ceará and 9 other locations) |
| Status | Recruiting |
| Started | January 10, 2023 |
| Main results expected | December 20, 2026 |
| Study ends | December 20, 2026 |
| Registry record updated | March 26, 2024 |
| Trial ID | NCT04945213 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 75 with moderate to severe acute traumatic brain injury and specific neurological assessments.
✕Probably not a fit
Patients with a history of epilepsy or seizures, or those who have previously used biperiden, will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of biperiden, an anticholinergic medication, in preventing post-traumatic epilepsy (PTE) in adults with moderate to severe traumatic brain injury (TBI). The study aims to determine the incidence and intensity of spontaneous seizures following TBI and assess the safety and cost-effectiveness of biperiden compared to a placebo. Participants will be monitored for side effects and overall outcomes to establish biperiden's potential as a preventive treatment for PTE.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce the occurrence of epilepsy in patients recovering from traumatic brain injuries.
How similar studies have gone: Previous studies in animal models have shown promising results for biperiden in reducing seizure incidence, but this approach is novel in human subjects.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Given informed consent * 18 - 75 years of age * GCS between 6 and 12 at hospital admission. GCS between 3 and 5 at hospital admission can be enrolled if patient was sedated at the accident scene with previous GCS between 6 and 15. * Moderate or severe acute traumatic brain injury * All genders * Brain CT scan with signs of of acute intraparenchymal hemorrhage and/or contusion * Able to receive the first dose of treatment or placebo within 18 hours of brain injury, Exclusion Criteria: * Previous use of biperiden * History of epilepsy (confirmed by patient chart) * History of seizures or use of antiepileptic medication * Pregnancy * Participation in another clinical trial at the time of randomization * History of neoplasia, neurodegenerative diseases; history of stroke, cognitive impairment, benign prostatic hyperplasia, atrioventricular block or any other cardiac arrhythmia, or glaucoma megacolon or mechanical obstruction * Homeless patient
Where it's running
-
Santa Casa de Misericórdia de Sobral
Sobral, Ceará, Brazil Recruiting -
Hospital São Rafael
Salvador, Estado de Bahia, Brazil Recruiting -
Associação Beneficente Santa Casa de Campo Grande
Campo Grande, Mato Grosso do Sul, Brazil Recruiting -
Hospital das Clínicas da Faculdade de Medicina da Universidade de Ribeirão Preto
Ribeirão Preto, São Paulo, Brazil Recruiting -
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
São Paulo, São Paulo, Brazil Recruiting -
Hospital Sirio-Libanes
São Paulo, Brazil Recruiting
Show 4 more locations
-
Instituto Doutor José Frota
Fortaleza, Ceará, Brazil Not yet recruiting -
Hospital Estadual Urgencia e Emergencia -HEUE
Vitória, Espírito Santo, Brazil Not yet recruiting -
Hospital São Vicente de Paulo
Passo Fundo, Rio Grande do Sul, Brazil Active not recruiting -
Hospital São Paulo, Universidade Federal de São Paulo
São Paulo, Brazil Not yet recruiting
Study contacts
- Principal investigator: Luiz E Mello, MD, PhD — Hospital Sirio-Libanês
- Study coordinator: Eliana Garzon, MD, PhD
- Email: eliana.garzon@hsl.org.br
- Phone: +55 (11) 98206-2308
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding brain function and cognitive outcomes after traumatic brain injury
This study is trying to see how blood flow and brain health after a serious head injury affect thinking and memory recovery one year later for those who have had a moderate to severe traumatic brain injury.
-
Comparing two group wellness programs for people with brain injuries and their caregivers
This study is testing two different online wellness programs to see if they can help people with brain injuries and Alzheimer's disease, along with their caregivers, feel better and improve their quality of life.
-
Online memory intervention for people with traumatic brain injury
This study tests whether an online memory training program can help people with moderate to severe traumatic brain injury improve their memory and brain health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.